The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Educational reference only. Nothing on this page constitutes medical advice or encourages personal use of this compound. Always consult a qualified healthcare provider before any decision involving your health.

Khavinson Bioregulator Cluster

Khavinson Bioregulator Cluster · Cortexin · Cardiogen · Crystagen · Bronchogen

C
Animal replicated
RouteInjectableGray-market only
C
Evidence grade: Animal replicated

Effect demonstrated in multiple animal studies; human data sparse or extrapolated. Grades summarize evidence quality, not whether a compound is appropriate, legal, or risk-free.

At a glance
What it is
Cortexin • CardioCytogen (Cardiogen) • Crystagen • Bronchogen — Tissue-Specific Bioregulator Peptides — Bioregulator, Tissue-Specific Peptide, Peptide Complex.
Why people use it
Used primarily for cognitive support and longevity and anti-aging.
What the evidence supports
Bronchogen is the Khavinson bioregulator targeted at bronchial and pulmonary epithelial tissue. The AEDL tetrapeptide represents the minimal active sequence identified from pulmonary tissue extracts.
If you only read one thing

Four Organ-Specific Bioregulators from the Russian Khavinson Research Tradition. The Theory That Short Peptides Regulate Gene Expression in a Tissue-Specific Way. Cortexin: A Russian-Approved Neuroprotective Extract with Multi-Receptor Activity. CardioCytogen (Ala-Glu-Asp-Arg): The Cardiac Fibroblast Modulator. Crystagen: Connective Tissue and Cartilage Bioregulator. Bronchogen: Pulmonary Bioregulator Tetrapeptide. The Shared Evidence Architecture That Applies to All Four.

Route / form

Same compound, route-specific context. Switch forms instead of opening separate pages.

Evidence fit
Route-specific

Use the route notes below to match form, goal, and evidence quality.

Route caveat
Protocol not standardized

No route-matched protocol rows were parsed for this form; use the route notes and full dosing chapter before comparing options.

Protocol anchor
Full dosing section

Open the full report at the dosing chapter for protocol rows, cycle context, and administration notes.

Typical dose snapshot
See route notes
Evidence varies by use case
Evidence reality check
Evidence snapshot
Bronchogen is the Khavinson bioregulator targeted at bronchial and pulmonary epithelial tissue. The AEDL tetrapeptide represents the minimal active sequence identified from pulmonary tissue extracts.
From the chapter quick-reference block.
Risk posture
No major flags listed
Review route-specific cautions before use.
Properties
Active malignancy: cautionSingle-lab provenanceNot injectable
Evidence
CAnimal replicated
Simple view

Need the deep dive?

The default page keeps the decision layer visible first: summary, routes, evidence, and risks. Open the full report for mechanisms, chapter sections, citations, updates, and print/share controls.

Check interactions